Mary Anna Jansen
Family Medicine · Aurora, INNPI 1972890481
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,605, 4.7 times the $345 reported in 2019.
Across 250 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$943
- Novo Nordisk$600
- AstraZeneca$478
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$419
- Amgen$325
- Lilly USA, LLC$224
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,705100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 50 | $943 |
| Novo Nordisk | 40 | $600 |
| AstraZeneca | 16 | $478 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $419 |
| Amgen | 22 | $325 |
| Lilly USA, LLC | 15 | $224 |
| GSK | 9 | $221 |
| Pfizer | 14 | $202 |
| Exact Sciences | 8 | $154 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $137 |
| Merck | 8 | $111 |
| MDD US Operations, LLC | 3 | $100 |
| Axsome Therapeutics, Inc. | 1 | $99 |
| Novartis | 5 | $85 |
| Bayer | 5 | $82 |
| Astellas Pharma US Inc | 3 | $66 |
| Sanofi-aventis U.S. LLC | 4 | $65 |
| Abiomed | 3 | $60 |
| Scpharmaceuticals Inc. | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $51 |
| Abbott | 2 | $45 |
| Johnson & Johnson(2 entities) | 2 | $31 |
| Nestle Healthcare Nutrition Inc. | 1 | $28 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| Amarin Pharma, Inc. | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$121
- BEXSERO$109
- BEVESPI AEROSPHERE$101
- FARXIGA$101
How this compares
$4,705 in reported general payments places this provider in the 85th percentile of 2,709 family medicine providers in Indiana.
Other family medicine in Aurora
- Richard TannerIndianapolis$1.6M
- James AndryBloomington$715K
- Richard FeldmanIndianapolis$476K
- Anthony InzerelloEvansville$308K
- Joe BanksIndianapolis$294K
- Steven GatewoodElwood$281K
- Shekar PushpalaCarmel$239K
- Victoria MoyerKokomo$188K
- Thomas KintanarFort Wayne$185K
- Jeffrey HiltzMuncie$177K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.